Epidemiological MIC cut-off values for tigecycline calculated from Etest MIC values using normalized resistance interpretation

Journal of Antimicrobial Chemotherapy

Volumn 57, Issue 3, 2006, Pages 498-505

  Kronvall, Göran ^a   Karlsson, Inga ^a   Walder, Mats ^b   Sörberg, Mikael ^a   Nilsson, Lennart E ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Antimicrobial susceptibility tests; Clinical microbiology; Drug resistance; MIC breakpoints; Wild type MIC distributions

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE;

ACCURACY; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CALCULATION; CONTROLLED STUDY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HISTOGRAM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; SPECIES; WILD TYPE;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; EPIDEMIOLOGIC METHODS; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; MODELS, BIOLOGICAL;

EID: 32644438347     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dki489     Document Type: Article

References (26)

1. Ringertz S, Olsson-Liljequist B, Kahlmeter G et al. Antimicrobial susceptibility testing in Sweden. II. Species-related zone diameter breakpoints to avoid interpretive errors and guard against unrecognized evolution of resistance. Scand J Inf Dis Suppl 1997; 105: 8-12.
2. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically - Fifth Edition. Approved Standard, M7-A5. Wayne, PA: NCCLS, 2000.
3. Williams JD. Prospects for standardisation of methods and guidelines for disc susceptibility testing. Eur J Clin Microbiol Inf Dis 1990; 9: 496-501.
4. Kahlmeter G, Brown DF, Goldstein FW et al. European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria. J Antimicrob Chemother 2003; 52: 145-8.
5. Kahlmeter G, Brown DFJ. Harmonization of antimicrobial breakpoints in Europe - can it be achieved? Clin Microbiol Newsl 2004; 26: 187-92.
6. Kronvall G, Kahlmeter G, Myhre E et al. A new method for normalized interpretation of antimicrobial resistance from disk test results for comparative purposes. Clin Microbiol Infect 2003; 9: 120-32.
7. Kronvall G. Determination of the real standard distribution of susceptible strains in zone histograms. Int J Antimicrobial Agents 2003; 22: 7-13.
8. Joneberg J, Rylander M, Galas MF et al. Analysis of parameters and validation of method for normalized interpretation of antimicrobial resistance. Int J Antimicrobial Agents 2003; 21: 525-35.
9. Zhanel GG, Homenuik K, Nichol K et al. The Glycylcyclines. A Comparative Review with the Tetracyclines. Drugs 2004; 64: 63-88.
10. Petersen PJ, Jacobus NV, Weiss WJ et al. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936). Antimicrob Agents Chemother 1999; 43: 738-44.
11. Gales AC and Jones RN. Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolates. Diagn Microbiol Infect Dis 2000; 36: 19-36.
12. Milatovic D, Schmitz FJ, Verhoef J et al. Activities of the glycylcycline tigecycline (GAR-936) against 1,924 recent European clinical bacterial isolates. Antimicrob Agents Chemother 2003; 47: 400-4.
13. Deshpande LM, Gales AC, Jones RN. GAR-936 (9-t-butylglycylamido-minocycline) susceptibility test development for streptococci, Haemophilus influenzae and Neisseria gonorrhoeae: preliminary guidelines and interpretive criteria. Int J Antimicrobial Agents 2001; 18: 29-35.
14. Betriu C, Culebras E, Rodriguez-Avial I et al. In vitro activities of tigecycline against erythromycin-resistant Streptococcus pyogenes and Streptococcus agalactiae: Mechanisms of macrolide and tetracycline resistance. Antimicrob Agents Chemother 2004; 48: 323-5.
15. Fritsche TR, Kirby JT, and Jones RN. In vitro activity of tigecycline (GAR-936) tested against 11,859 recent clinical isolates associated with community-acquired respiratory tract and gram-positive cutaneous infections. Diagn Microbiol Infect Dis 2004; 49: 201-9.
16. Bouchillon SK, Hoban DJ, Johnson BM et al. In vitro evaluation of tigecycline and comparative agents in 3049 clinical isolates: 2001 to 2002. Diagn Microbiol Infect Dis 2005; 51: 291-5.
17. Bauer G, Berens C, Projan SJ et al. Comparison of tetracycline and tigecycline binding to ribosomes mapped by dimethylsulphate and drug-directed Fe2+ cleavage of 16S rRNA. J Antimicrob Chemother 2004; 53: 592-9.
18. Kronvall G, Hagelberg A. Numerical evaluation of minimal biochemical test combinations for the identification of Enterobacteriaceae species. APMIS 2002; 110: 451-7.
19. Reyn A, Weis Bentzon M, Ericsson H. Comparative investigations of the sensitivity of N. gonorrhoeae to penicillin. Acta Pathol Microbiol Scand 1963; 235-55.
20. Soothill JS, Ward R, Girling AJ. The IC50: An exactly defined measure of antibiotic sensitivity. J Antimicrob Chemother 1992; 29: 137-9.
21. Kronvall G, Ringertz S, Nyström S et al. Comparison of 30 μg and 120 μg gentamicin disks for the prediction of gentamicin resistance in Enterococcus faecalis. APMIS 1991; 99: 887-92.
22. Visalli MA, Murphy E, Projan SJ et al. AcrAB multidrug efflux pump is associated with reduced levels of susceptibility to tigecycline (GAR-936) in Proteus mirabilis. Antimicrob Agents Chemother 2003; 47: 665-9.
23. Ruzin A, Keeney D, Bradford PA. AcrAB efflux pump plays a role in decreased susceptibility to tigecycline in Morganella morganii. Antimicrob Agents Chemother 2005; 49: 791-3.
24. Olsson-Liljequist B, Forsgren A. Antimicrobial susceptibility testing in Sweden. I. The work of the Swedish Reference Group for Antibiotics (SRGA and SRGA-M). Scand J Infect Dis Suppl 1997; 105: 5-7.
25. Kronvall G, Runehagen A. Förbättrad känslighetsbedömning av bakterier medelst artrelaterat SIR-system (Improved determination of antibiotic susceptibility of bacteria using species-related SIR interpretation). Läkartidningen 1981; 78: 3483-5.
26. Turnidge J, Kahlmeter G, Kronvall G. Statistical characterisation of bacterial wild-type distributions of MIC-values and the determination of epidemiological cut-off values. Clin Microbiol Infect 2006; 12: In press.